FENGBEI BIOTECH: 35.9 million new shares will be listed on the main board on November 5, highlighting multiple risks

Zhitong
2025.11.03 11:07

FENGBEI BIOTECH announced that the company's ordinary shares in RMB will be listed on the main board of the Shanghai Stock Exchange on November 5, 2025, with the stock code 603334. After the initial public offering, the total share capital will be 14.35 million shares, with 3.59 million shares being issued, all of which are new shares. The company reminds investors to pay attention to the investment risks in the early stages of listing, including the relaxation of price fluctuation limits, low circulating shares, valuation, margin financing, and other risks. The issuance price is 24.49 yuan per share, corresponding to a diluted price-to-earnings ratio of 30.47 times after deducting non-recurring items for 2024, which is lower than the industry average and the average level of comparable companies

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer